Topic: Cardiovascular Endocrinology

SY62 - Primary Aldosteronism Genotypes and Clinical Implications

Symposium Chair(s)

• 

  Gail Adler, MD,PhD (she/her/hers)

  Professor of Medicine
  Brigham and Women's Hospital
  Boston, MA, United States

  Disclosure(s): No financial relationships to disclose
• 

  Elisabeth Ng, MBBS FRACP (she/her/hers)

  Endocrinologist
  Centre for Endocrinology and Reproductive Health
  Hudson Institute of Medical Research
  Melbourne, Australia

  Disclosure(s): No financial relationships to disclose

This symposium will cover translational and clinical advances in primary aldosteronism, including:

Common primary aldosteronism genotypes and their clinical implications;

Emerging molecular imaging tools for guiding primary aldosteronism subtyping, surgery, and ablative procedures;

New developments in medical therapies for primary aldosteronism (role of aldosterone synthase inhibitors and evolving treatment targets);

Complexities of primary aldosteronism diagnosis and treatment in patients with chronic kidney disease.

Presentations:

• 9:00 AM - 9:22 AM CT

  Complexities of PA Diagnosis in Chronic Kidney Disease
  

  Symposium Speaker: Vivek Bhalla, MD – STANFORD UNIVERSITY
• 9:22 AM - 9:44 AM CT

  Rethinking Diagnosis: From AVS to Molecular Imaging and Potential Therapeutics
  

  Symposium Speaker: Mark Gurnell
• 9:44 AM - 10:06 AM CT

  Medical Therapy for PA: New Agents, New Goals
  

  Symposium Speaker: Paolo Mulatero, MD – University of Torino
• 10:06 AM - 10:30 AM CT

  Genomics of Primary Aldosteronism: Insights to Advance Precision Diagnosis and Therapy
  

  Symposium Speaker: William Rainey, MS PhD – University of Michigan